A new study has revealed that omega-3 capsules don’t increase the risk of prostate cancer. Researchers at the Intermountain Healthcare Heart Institute in Salt Lake City conducted the study. They measured how omega-3 helps patients in recovery. The study concluded taking omega-3 pills are safe. Also, omega-3 rich fish don’t put patients at risk. The findings contradict the 2013 research that popular dietary supplement increases the risk of prostate cancer. Researchers at the 2019 American Heart Association Scientific Sessions, Philadelphia referred to two new studies to back their claim. The first study involved 87 patients. These patients were part of the INSPIRE Registry. All the patients developed prostate cancer. These patients were also tested for plasma levels of docosahexaenoic and eicosapentaenoic acids. Both the DHA and EPA are two common types of Omega-3 fatty acids. A separate group of 149 men, the researchers found that higher levels of omega-3 were not linked with increased prostate cancer risk.
In the second study, a total of 894 patients were involved. All were undergoing coronary angiography after cardiac arrest. These patients had no past history of heart or coronary artery disease. However, after the first angiogram, 40% of these patients were diagnosed with severe disease. Around 10% had developed the three-vessel disease. Researchers measured their plasma levels of omega-3 metabolites. They were also tested for DHA and EPA. Researchers said that they found patients with higher rates of omega-3 metabolites had a lower risk. Physician assistant and researcher Viet T Le said the study was important because researchers watched how omega-3 helps patients in recovery. Le added that the study found no link between omega-3 and prostate cancer.
Researchers instead noted they observed a direct link between higher levels of omega-3 and survival rate of heart patients. Le even recommended omega-3 for patients to save their hearts as he ruled out to put them at risk for prostate cancer. The study was conducted in view of the 2013 findings. Then the study was published in the Journal of the National Cancer Institute. It suggested a link between higher omega-3 plasma levels and the development of prostate cancer.